Effect of Systemic Intravenous Infusion of PGF-2 Alpha and 13,14-dihydro-15-keto-PGF-2 Alpha on the Release of Oxytocin-associated Neurophysin from the Ovary in the Ewe

Systemic intravenous infusion of physiological concentrations of PGF-2 alpha and its major metabolite, 13, 14-dihydro-15-keto-PGF-2 alpha (PGFM) into non-pregnant ewes possessing a corpus luteum induced the release of oxytocin-neurophysin. These results suggest that, during luteolysis, endogenous release of uterine PGF-2 alpha would be able to stimulate the release of ovarian oxytocin and oxytocin-neurophysin from the ovary.